Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening

被引:12
|
作者
Rohner, Eliane [1 ]
Edelman, Claire [2 ]
Sanusi, Busola [3 ]
Schmitt, John W. [2 ]
Baker, Anna [1 ]
Chesko, Kirsty [4 ]
Faherty, Brian [4 ]
Gregory, Sean M. [4 ]
Romocki, LaHoma S. [5 ]
Sivaraman, Vijay [6 ]
Nelson, Julie A. E. [7 ]
O'Connor, Siobhan [8 ]
Hudgens, Michael G. [3 ]
Knittel, Andrea K. [9 ]
Rahangdale, Lisa [9 ,10 ]
Smith, Jennifer S. [1 ,10 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA
[4] Becton Dickinson & Co, Sparks, MD USA
[5] North Carolina Cent Univ, Dept Publ Hlth Educ, Durham, NC USA
[6] North Carolina Cent Univ, Dept Biol & Biomed Sci, Durham, NC USA
[7] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA
[8] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[9] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; RISK; SPECIMENS; WOMEN; POPULATION; CONCORDANCE; PREVENTION; COHORT;
D O I
10.1158/1055-9965.EPI-20-0674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected cervico-vaginal swabs could increase cervical cancer screening coverage, although triage strategies are needed to reduce unnecessary colposcopies. We evaluated the use of extended hr-HPV genotyping of self-collected samples for cervical cancer screening. Methods: We recruited women ages 25-65 years at two colposcopy clinics in North Carolina between November 2016 and January 2019, and obtained self-collected cervico-vaginal samples, provider-collected cervical samples, and cervical biopsies from all enrolled women. Self- and provider-collected samples were tested for 14 hr-HPV genotypes using the Onclarity Assay (Becton Dickinson). We calculated hr-HPV genotype-specific prevalence and assessed agreement between results in self- and provider-collected samples. We ranked the hr-HPV genotypes according to their positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or higher (CIN2+). Results: A total of 314 women participated (median age, 36 years); 85 women (27%) had CIN2+. More women tested positive for any hr-HPV on self-collected (76%) than on provider-collected samples (70%; P = 0.009) with type-specific agreement ranging from substantial to almost perfect. HPV-16 was the most common genotype in self- collected (27%) and provider-collected samples (20%), and HPV-16 prevalence was higher in self- than provider-collected samples (P < 0.001). In self- and provider-collected samples, HPV-16 had the highest PPV for CIN2+ detection. Conclusions: Overall sensitivity for CIN2+ detection was similar for both sample types, but the higher HPV-16 prevalence in self-collected samples could result in increased colposcopy referral rates. Impact: Additional molecular markers might be helpful to improve the triage of women who are hr-HPV positive on self-collected samples.
引用
收藏
页码:2651 / 2661
页数:11
相关论文
共 50 条
  • [31] Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China
    Song, Fangbin
    Belinson, Jerome L.
    Yan, Peisha
    Huang, Xia
    Wang, Chun
    Du, Hui
    Qu, Xinfeng
    Wu, Ruifang
    GYNECOLOGIC ONCOLOGY, 2021, 162 (02) : 322 - 330
  • [32] HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
    Lagos, Marcela
    Van De Wyngard, Vanessa
    Poggi, Helena
    Cook, Paz
    Viviani, Paola
    Barriga, Maria Isabel
    Pruyas, Martha
    Ferreccio, Catterina
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [33] HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
    Marcela Lagos
    Vanessa Van De Wyngard
    Helena Poggi
    Paz Cook
    Paola Viviani
    María Isabel Barriga
    Martha Pruyas
    Catterina Ferreccio
    Infectious Agents and Cancer, 10
  • [34] Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial
    Hellsten, Caroline
    Ernstson, Avalon
    Bodelsson, Gunilla
    Forslund, Ola
    Borgfeldt, Christer
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2021, 30 (04) : 334 - 340
  • [35] Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention
    Gradissimo, Ana
    Burk, Robert D.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (04) : 379 - 391
  • [36] ACCURACY OF SELF VERSUS PROVIDER COLLECTED VAGINAL/CERVICAL SAMPLES TO DETECT HR HPV IN HIV AFFECTED AND UNAFFECTED WOMEN IN KENYA
    Rosen, B.
    Namugga, J.
    Orang'o, E.
    Itsura, P.
    Tonui, P.
    Ganda, G.
    Kapten, M.
    Brown, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 495 - 495
  • [37] Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
    Shih, Yu-Hsiang
    Sun, Lou
    Hsu, Shih-Tien
    Chen, Ming-Jer
    Lu, Chien-Hsing
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2023, 15 : 1421 - 1429
  • [38] HPV self-testing and cervical cancer screening coverage
    Gravitt, Patti E.
    Rositch, Anne F.
    LANCET ONCOLOGY, 2014, 15 (02): : 128 - 129
  • [39] The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
    Song, Fangbin
    Du, Hui
    Wang, Chun
    Huang, Xia
    Wu, Ruifang
    PLOS ONE, 2020, 15 (06):
  • [40] Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis
    Smith, Megan A.
    Hall, Michaela T.
    Saville, Marion
    Brotherton, Julia M. L.
    Simms, Kate T.
    Lew, Jie-Bin
    Bateson, Deborah
    Skinner, S. Rachel
    Kelaher, Margaret
    Canfell, Karen
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (02) : 268 - 277